Hodgkin Lymphoma Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 AFMD 1,2,3 Pullback Bullish Bullish Swing Setup
2021-04-16 AFMD Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-16 AFMD Calm After Storm Range Contraction
2021-04-16 SGEN Bollinger Band Squeeze Range Contraction

Recent News for Hodgkin Lymphoma Stocks

Date Stock Title
Apr 16 SGEN Is Weakness In Seagen Inc. (NASDAQ:SGEN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Apr 15 STRO Sutro Biopharma (STRO) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow
Apr 15 AFMD Why Affimed N.V. Stock Dropped Today
Apr 15 AFMD Affimed N.V. (AFMD) CEO Adi Hoess on Q4 2020 Results - Earnings Call Transcript
Apr 15 AFMD ‘Natural Killer Cells’ and Other Promising Cancer Treatments
Apr 15 AFMD Affimed trades lower following FY bottom-line miss
Apr 15 STRO Sutro Biopharma earns milestone payment from Merck collaboration
Apr 15 STRO Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck
Apr 15 AFMD Affimed EPS misses by €0.48, beats on revenue
Apr 15 AFMD Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress
Apr 15 AFMD Affimed NV to Host Earnings Call
Apr 15 AFMD Earnings Scheduled For April 15, 2021
Apr 12 AFMD Company News for Apr 12, 2021
Apr 12 AFMD Affimed shares gain 5% on encouraging AFM24 data in EGFR-expressing solid tumors
Apr 12 AFMD Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-targeting Therapy for Solid Tumors as Monotherapy and in Combination with Adoptive NK Cell Transfer at AACR Virtual Annual Meeting I
Apr 12 AFMD 51 Biggest Movers From Friday
Apr 12 SGEN Seagen: The New Oncology Hope
Apr 10 CTIC The Past Week's Notable Insider Buys Included Biotechs, Public Offerings, A SPAC And More
Apr 10 AFMD The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Related Industries: Biotechnology

Hodgkin's lymphoma (HL) is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affected may feel tired or be itchy.About half of cases of Hodgkin's lymphoma are due to Epstein–Barr virus (EBV). Other risk factors include a family history of the condition and having HIV/AIDS. There are two major types of Hodgkin lymphoma: classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Diagnosis is by finding Hodgkin's cells such as multinucleated Reed–Sternberg cells (RS cells) in lymph nodes. The virus-positive cases are classified as a form of the Epstein-Barr virus-associated lymphoproliferative diseases.Hodgkin lymphoma may be treated with chemotherapy, radiation therapy, and stem cell transplant. The choice of treatment often depends on how advanced the cancer has become and whether or not it has favorable features. In early disease, a cure is often possible. The percentage of people who survive five years in the United States is 86%. For those under the age of 20, rates of survival are 97%. Radiation and some chemotherapy drugs, however, increase the risk of other cancers, heart disease, or lung disease over the subsequent decades.In 2015 about 574,000 people had Hodgkin's lymphoma, and 23,900 died. In the United States, 0.2% of people are affected at some point in their life. The most common age of diagnosis is between 20 and 40 years old. It was named after the English physician Thomas Hodgkin, who first described the condition in 1832.

More about Hodgkin Lymphoma
Browse All Tags